Immediate Versus Early Endovenous Ablation In Venous Ulcer
NCT ID: NCT03795064
Last Updated: 2024-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2018-12-05
2023-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Finnish Venous Ulcer Study (FINNULCER Study)
NCT04737941
Early Glue Saphenous Vein Ablation With Compression Versus Compression Alone in the Healing of the Venous Ulcer
NCT03666754
Venous Ulcer Treatment With Foam Versus Conservative Treatment
NCT01594658
Compression And Functional Ability After Endovenous Varicose Vein Treatment
NCT03613376
Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy
NCT02890563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate Intervention
Patients in this group will be treated with foam sclerotherapy immediately in the first visit to outpatient clinic (immediate intervention).
Foam sclerotherapy
Foam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area.
Endothermal ablation
Endothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable.
Early Intervention
Patients in this group will be treated with foam sclerotherapy in the following visit to outpatient clinic at four weeks (early intervention).
Foam sclerotherapy
Foam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area.
Endothermal ablation
Endothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Foam sclerotherapy
Foam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area.
Endothermal ablation
Endothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ulcer area \> 1cm2
* Palpable distal pulses / Ankle-brachial index \> 0,8 / Toe-brachial index \> 70mmhg (at least one criteria must be met)
Exclusion Criteria
* Pregnancy
* General contraindications for foam sclerotherapy
* Ulcers requiring operation theater revision
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oulu University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Toni Pihlaja
Vascular Specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oulu University Hospital, Vascular Department
Oulu, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pihlaja T, Ohtonen P, Romsi P, Pokela M. Sub-ulcer foam sclerotherapy in patients with venous ulceration: A randomized controlled trial. Phlebology. 2025 Jun;40(5):324-329. doi: 10.1177/02683555241304030. Epub 2024 Nov 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
268/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.